Zaghouani; Habib

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zaghouani; Habib.The latest application filed is for "methods and compositions for the treatment and/or prevention of type 1 diabetes".

Company Profile

1.10.16

Zaghouani; Habib - Columbia MO
Zaghouani; Habib - Knoxville TN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for the treatment and/or prevention of type 1 diabetes Grant 11,338,036 - Zaghouani May 24, 2	2022-05-24
Methods And Compositions For The Treatment And/or Prevention Of Type 1 Diabetes App 20220008535 - Zaghouani; Habib	2022-01-13
Antigen-specific Immune Modulation App 20200030377 - Zaghouani; Habib	2020-01-30
Methods And Compositions For The Treatment And/or Prevention Of Type 1 Diabetes App 20160015811 - Zaghouani; Habib	2016-01-21
Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes Grant 8,609,091 - Zaghouani , et al. December 17, 2	2013-12-17
Methods and compositions for preventing the onset of type 1 diabetes Grant 8,603,471 - Zaghouani , et al. December 10, 2	2013-12-10
Methods and compositions reversing pre-diabetes using fusion proteins comprising a GAD peptide Grant 8,603,472 - Zaghouani , et al. December 10, 2	2013-12-10
Treatment Of Type 1 Diabetes Before And After Expression Of Predisposition Markers App 20100278823 - Zaghouani; Habib ; et al.	2010-11-04
Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes Grant 7,744,876 - Zaghouani , et al. June 29, 2	2010-06-29
Coupling Of Peripheral Tolerance To Endogenous Il-10 Promotes Effective Modulation Of T Cells And Ameliorates Autoimmune Disease App 20090280132 - Zaghouani; Habib	2009-11-12
Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors App 20090181011 - Zaghouani; Habib	2009-07-16
Coupling Of Peripheral Tolerance To Endogenous Il-10 Promotes Effective Modulation Of T Cells And Ameliorates Autoimmune Disease App 20070218053 - Zaghouani; Habib	2007-09-20
Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors App 20070122409 - Zaghouani; Habib	2007-05-31
Compositions And Methods For Treating, Preventing And/or Reversing Type-1 Diabetes App 20070041973 - Zaghouani; Habib ; et al.	2007-02-22
Treatment of type 1 diabetes before and after expression of predisposition markers App 20060210562 - Zaghouani; Habib ; et al.	2006-09-21
Compositions and methods for treating and preventing type-1 diabetes App 20060115478 - Zaghouani; Habib ; et al.	2006-06-01
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors App 20060034864 - Zaghouani; Habib	2006-02-16
Sustained treatment of type 1 diabetes after expression of predisposition markers App 20040126374 - Zaghouani, Habib ; et al.	2004-07-01
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors Grant 6,737,057 - Zaghouani May 18, 2	2004-05-18
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors App 20030103967 - Zaghouani, Habib	2003-06-05
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors App 20020081298 - Zaghouani, Habib	2002-06-27
Coupling of peripheral tolerance to endogenous IL-10 promotes effective modulation of T cells and ameliorates autoimmune disease App 20020038002 - Zaghouani, Habib	2002-03-28
Chimeric antibodies comprising antigen binding sites and B and T cell epitopes Grant 5,969,109 - Bona , et al. October 19, 1	1999-10-19

Company Registrations

NCAGE Code	43GM7	ZAGHOUANI HABIB
CAGE Code	43GM7	ZAGHOUANI, HABIB
DUNS	603212684	ZAGHOUANI, HABIB

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.